---

An overview of the monkeypox

Full Text PDF Share on Facebook Share on Twitter

---

Short Communication

Author Details : Raunakkumar Chaurasiya*, Jayalalita Kamble, Yeshwant Kumar, Rambishwash Giri, Dhiraj Chaudhary, Rahul Singh, Cruciforth Kharsyntiew

Volume : 8, Issue : 2, Year : 2023

Article Page : 130-133

https://doi.org/10.18231/j.ijcaap.2023.022

Suggest article by email

Get Permission

Abstract

Smallpox-like symptoms are caused by the human monkeypox orthopoxvirus, a zoonotic orthopoxvirus. The zoonotic human monkeypox was detected in 1970, twelve years after the monkeypox virus was found in a Danish lab in 1958. It has lately been documented in cases outside of Africa, and it has spread to other regions of Africa. (mainly West and Central Africa). The genesis, epidemiology, and ecology of the disease are still largely unknown, which has caused a rise in the frequency and geographic dispersion of human monkeypox cases in recent years. 8 days on average were needed for incubation. (range 4–14 days). A multi-nation outbreak of human monkeypox infections, involving transmission from person to person, was documented in Europe and North America in May 2022. Monitoring and epidemiological analysis need to be more precise in order to calculate the effect on public health and develop policies to reduce the risk of a larger spread of disease. Small viral epidemics with mortality rates around 10% and rates of secondary human-to-human transmission around the same percentage are frequent in tropical Central and West Africa. On July 31, 2022, the first case of monkeypox mortality was reported in India; the victim was a 22-year-old man who had recently returned from the United Arab Emirates. In light of the continuous outbreaks throughout the world, we provide current information on monkeypox for medical professionals in this overview. There is a zoonotic orthopoxvirus that produces human monkeypox. However, ST 246 has been found to be effective in vivo and in vitro in infected animals, and experiments were safely carried out on non-infected humans. ST 246 has not been tested for its effectiveness on monkey pox or orthopox-infected individuals.
 

Keywords: Monkeypox, Orthopoxvirus, Human­to­human transmission, Treatment

How to cite : Chaurasiya R, Kamble J, Kumar Y, Giri R, Chaudhary D, Singh R, Kharsyntiew C, An overview of the monkeypox. IP Int J Compr Adv Pharmacol 2023;8(2):130-133

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.